Enhanced Recovery After Cesarean Section With Low Dose Intrathecal Morphine.

• Status: Recruiting
• Trial end date: 2021-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study is designed to see the effect of low dose intrathecal morphine on promting enhanced recovery after cesarean delivery with early ambulation and reduction of hospital stay.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Minia University
• Treatments: Bupivacaine; Morphine

Criteria

Inclusion Criteria:

• Females scheduled for cesarean section

• Age: 16-45 yrs.

• Gestation age >38 weeks.

• ASA I,II

Exclusion Criteria:

• Refusal to participate.

• Significant cardiac, hepatic or renal dysfunction.

• History of chronic itching problem, or hyperemesis during pregnancy